3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
4
Breast Neoplasms
3
Melanoma
2
Colorectal Neoplasms
2
Untreated Resectable Pancreatic Adenocarcinoma
1
Resectable Localized Prostate Cancer
1
Prostatic Neoplasms
1
Prostate Cancer Recurrent
1
Pancreatic Ductal Adenocarcinoma
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neoplasms
1
Neoplasm, Residual
1
Liver Neoplasms
1
Klatskin Tumor
1
Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer
1
Glioma
1
Gastrointestinal Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Adenocarcinoma
1
Interventions
tocilizumab
2
siltuximab
2
fludarabine phosphate
2
fludarabine
2
Interleukin 1 Receptor Antagonist Protein
2
Cyclophosphamide
2
AP 1903 reagent
2
talquetamab
1
obinutuzumab
1
glofitamab
1
axicabtagene ciloleucel
1
Oxaliplatin
1
Gemcitabine
1
Dexamethasone
1
Calcium Dobesilate
1
Bendamustine Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Cytokine Release Syndrome
×
Hydroxychloroquine
×
1 year
×
Clear all
No trials found.